Skip to main content

AlphaLISA Human KRAS WT GTP Binding Kit, 500 Assay Points

The AlphaLISA® Human KRAS WT GTP Binding Kit is designed for the detection of binding activity between human KRAS wild type (WT) and GTP, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This KRAS GTP assay can be used to identify KRAS WT / GTP inhibitors.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Part number: AL3148C
Unit Size: 500 Assay Points
List price: USD 3,538.00
Your price:
USD 3,538.00
USD 3,538.00 /each
Part number: AL3148F
Unit Size: 5,000 Assay Points
List price: USD 17,420.00
Your price:
USD 0.00
USD 17,420.00 /each


KRAS is member of the Rat sarcoma (RAS) oncogene family and is a small GTPase implicated in various biological processes, such as cell proliferation, cell survival, and cell metabolism. This proto-oncogene is well known to be mutated in many cancer subtypes, inducing uncontrolled proliferation and cell metabolism modifications. It thereby contributes to the Warburg effect in cancer cells. The on/off state of the KRAS protein is determined by nucleotide binding. Only in the GTP bound active state is KRAS able to bind and activate effector proteins. GTP binding can be catalyzed by guanine nucleotide exchange factors for RAS, and GTP hydrolysis can be accelerated by GTPase-activating proteins (GAPs). Identifying new KRAS GTP competitors with a KRAS assay is therefore a relevant strategy to control biological processes involved in cancer growth by reducing the KRAS activity, as well as the associated pathways. KRAS WT GTP assays screen for specific KRAS WT compounds.

  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 20 µL reaction volume (5 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 20 µL reaction volume (5 µL of sample).
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Small sample volume

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.


Protein Binding
Protein Detection
Assay Technology
Automation Compatible
Detection Method
Experimental Type
In vitro
Target Species
Therapeutic Area
Unit Size
500 Assay Points

Video gallery


1-1 of 1 Resources
Whitepaper Icon
KRAS biomarker becomes a target of choice in certain cancer therapies

Get the latest insights on KRAS and see how it has switched from being an undruggable to a druggable cancer target.

In this white...

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon